Carboprost tromethamine
卡前列素氨丁三醇
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameCarboprost tromethamine
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1979/01/09
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPharmacia & Upjohn CoPfizer IncNorthwestern University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A